Last Updated: 11/19/2014 22:26:09
CFD Stock Chart - 1 Month
CFD Stock Chart - 3 Month
CFD Stock Chart - 6 Month
CFD Stock Chart - 1 Year
CFD Stock Chart - 2 Year
Yiren's Stormy Seas: A Tale of Instability If you're holding a stake in Yiren Digital Ltd. (NYSE: YRD), you're likely feeling the heat right now. It's been a ride down a bumpy road with stock prices taking a nosedive—plummeting 44.05% on news that's got investors seeing red. The Nuts and Bolts of the Class Action What's the big fuss, you ask? Well, the lawsuit is no...
Continue Reading
Looks like Lululemon Athletica Inc. (NASDAQ: LULU) is in the hot seat, and not in the cozy yoga session kind of way. Investors are gearing up for a legal face-off thanks to a class action lawsuit alleging some serious corporate sleight of hand. What Triggered This Legal Storm? Turns out, between March 18 and September 3, 2026, things didn't go as planned for Lululemon....
Continue Reading
Redefining Accessibility through Technology Tech giant Bark is making waves with its fresh blueprint for accessible technology. Recently, Wisconsin gave a nod to Bark Phone and Bark Watch through the state’s IRIS and CLTS programs, aiming to support individuals with disabilities. This development could reshape our understanding of technology beyond the binary choice of...
Continue Reading
Investor Deadline Looms for BETR Losses Ah, the tangled web of finance promises and posturing! Investors in Better Home & Finance Holding Company (NASDAQ: BETR) are now standing at a financial crossroads, thanks to an unfolding legal drama. You've got until November 20, 2026, to align your ducks and join a federal securities class action lawsuit, put forth by Hagens...
Continue Reading
Reassessing Bonds Post-2026 Midterms When the election circus packs up its tents, investors like us are left standing in the wreckage, trying to figure out what's next for our portfolios. That's just where One Oak Capital Management's latest research fits into our jigsaw—exploring how the political winds can ripple through the layers of the bond market. Federal...
Continue Reading
CorelDRAW: A Design Powerhouse Without Recurring Bills? Every so often, a software option comes along that piques my interest, and right now, it's CorelDRAW Graphics Suite. Consumer365 has shone a light on this nifty tool for its one-time purchase model—a breath of fresh air in the age of endless subscriptions that seem to drain more than enthusiasm as the months roll...
Continue Reading
A Shot in the Arm or a Sore Spot? INOVIO Pharmaceuticals is diving headfirst into the capital markets with a $75 million public offering, and let me tell you, the road ahead isn't paved with gold, yet. They've set out to raise funds by pricing 58,747,235 shares at $1.05 a pop, which might have you scratching your head if you're holding INO shares already. Breaking Down...
Continue Reading
The wheels are literally in motion in South Broward, with Memorial Healthcare System's Mobile Health Program taking healthcare to the doorstep of thousands. This killer initiative slashed hospital admissions by a nifty 62% among its users in 2025, and they ain't slowing down in 2026. Talk about bringing the doctor to the streets and changing lives! Healthcare On Wheels:...
Continue Reading
Profit Surges Despite Revenue Dip When a company's profit jumps up while sales take a slight nosedive, they're doing something right—or maybe they've got a lucky rabbit's foot. Hanon Systems just rolled out their numbers for Q3 2026, and here's what's cooking: operating profit soared a whopping 26.6% year-on-year to hit KRW 120.6 billion, even while revenue stumbled a...
Continue Reading
Global Warming: A Battle Heating Up Fast It's like trying to run uphill while carrying the baggage of outdated promises. We’ve got business bigwigs rallying at COP31, demanding the world to get serious about clean energy. If they don’t, we're looking at warming rocketing up to 2.6°C come year 2100. Who's listening though? The Call for Clean Electrification This mob,...
Continue Reading
Rhythm Pharmaceuticals' Financial Performance for Q4 2024 Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company dedicated to helping patients with rare neuroendocrine diseases, recently unveiled its preliminary financial results for the last quarter and the entirety of 2024. It has been reported that the company anticipates net revenues from global...
Continue Reading
Understanding the Rocket Lab Securities Fraud Case The recent developments surrounding Rocket Lab USA, Inc. (NASDAQ: RKLB) have created a significant opportunity for investors seeking justice. If you purchased Rocket Lab securities within a specific time frame, you may find that legal action could be a path to compensation for potential losses incurred due to misleading...
Continue Reading
Allegiant Expands Nonstop Routes with Exciting New Additions Allegiant Travel Company (NASDAQ: ALGT) has just announced an exciting expansion of its nonstop flight routes, adding connections to eight diverse cities. This initiative reflects Allegiant's commitment to serving travelers with budget-friendly options that help make dream vacations a reality. As the airline...
Continue Reading
Understanding the Class Action Lawsuit Against Solaris Energy Infrastructure Investors are being alerted about a significant class action lawsuit involving Solaris Energy Infrastructure, Inc. (NYSE: SEI). This development has the potential to impact numerous shareholders, making it crucial for investors to stay informed. Details of the Allegations The lawsuit alleges...
Continue Reading
ARTHEx Biotech Participates in Healthcare Conference ARTHEx Biotech S.L. is stepping into the spotlight as it prepares for participation in a prominent virtual healthcare conference. This event, known as the 24th Annual Needham Virtual Healthcare Conference, will serve as a platform for the company to engage with potential investors and showcase its advancements in...
Continue Reading